Detalles de la búsqueda
1.
High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance.
Haematologica
; 104(11): 2249-2257, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30890600
2.
Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura.
Blood Adv
; 6(24): 6219-6227, 2022 12 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35930694
Resultados
1 -
2
de 2
1
Próxima >
>>